Clinical trials: sponsored by University Health Network, Toronto
Castration Resistant Prostate Cancer
Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer
This is a single-institution, single-arm, open-label Phase 2 trial evaluating evofosfamide in subjects with M1 CRPC who fail first-line ARSIs.
- Trial name
- EVO (NCT06836726)
- Testing
- Evofosfamide
- Where
- Canada
- Volunteers
- 35 people
- Sponsor
- University Health Network, Toronto
Myeloproliferative Neoplasm (MPN), Pregnancy
Study of Pregnancy in Patients With Myeloproliferative Neoplasms
This is a study to evaluate pregnancy in patients with myeloproliferative neoplasms. The main endpoint of this study is to determine the number of live births in pregnant MPN patients who are managed by a risk-adapted algorithm
- Trial name
- NCT07832513
- Testing
- Risk-adapted algorithm
- Volunteers
- 30 people
- Sponsor
- University Health Network, Toronto
Gynecologic Cancer
Impact of Cultural and Linguistic Backgrounds on Patient Care and Experience of Women With Gynecologic Malignancies
Purpose of this study to delineate the attitudes and experiences of patients, interpreters and cancer care professionals involved in the care of oncology patients with gynecologic malignancies with cultural and linguistic…
- Trial name
- iCALD-2 (NCT05971303)
- Testing
- Questionnaire
- Where
- Canada
- Volunteers
- 45 people, healthy volunteers welcome
- Sponsor
- University Health Network, Toronto
Vaginal Cancer
Vagina-View Safety and Imaging Feasibility
This prospective, single-arm feasibility study evaluates the use of the Vagina-View (VV) device to guide the placement of a multichannel applicator (MCA) during vaginal brachytherapy.
- Trial name
- Vagina-View (NCT07818850)
- Testing
- Vagina-View (VV) device
- Where
- Canada
- Volunteers
- 10 people
- Sponsor
- University Health Network, Toronto
Kidney Transplant Recipient
Semaglutide for the Prevention Of Post-Transplant Diabetes Mellitus
The study aims to determine the short-term efficacy, mechanisms and safety of 24 weeks of semaglutide therapy in 37 KTR at risk of post-transplant diabetes mellitus (PTDM).
- Trial name
- SPOT-DM (NCT06913023)
- Testing
- Semaglutide 0.25 mg, Semaglutide 0.5 mg, Semaglutide 1.0 mg
- Where
- 2 sites in Canada
- Volunteers
- 37 people
- Sponsor
- University Health Network, Toronto
Histopathologically or Cytologically Confirmed Solid Tumor Who Require Palliation Radiation Therapy to a Lesion ≥5cm
Lattice Radiation Therapy Versus Conventional Radiation Therapy for the Palliation of Large Tumors
The goal of this randomized, phase III trial is to to determine if Spatially Fractionated Lattice Radiotherapy (SFRT) known as LATTICE therapy, leads to a greater reduction in pain or discomfort compared with conventional…
- Trial name
- LATTICE-PAL (NCT07444775)
- Testing
- Conventional Radiation Therapy, Spatially fractionated radiation therapy
- Where
- Canada
- Volunteers
- 148 people
- Sponsor
- University Health Network, Toronto
Laparoscopic Cholecystectomy
AI and Safety in Laparoscopic Cholecystectomy: A Randomized Controlled Trial
Today, the majority of gallbladder removals surgeries are done using minimally invasive techniques through small cuts to help patients recover faster.
- Trial name
- NCT07186803
- Testing
- Artificial Intelligence Guidance Models
- Where
- 2 sites in Canada
- Volunteers
- 64 people
- Sponsor
- University Health Network, Toronto
Squamous Cell Carcinoma of Head and Neck
HN-BIO 02: A Phase II Randomized Study of the Effects of Delayed Elective Radiotherapy on Head and Neck MRI and Immune Response Biomarkers
This is a single centre prospective exploratory study of effects of delayed radiation therapy on adaptive immune response in patients with newly diagnosed (head and neck squamous cell carcinoma) HNSCC receiving curative…
- Trial name
- HN-Bio 02 (NCT06487403)
- Testing
- Standard of care external beam radiotherapy (single integrated boost), Standard of care external beam radiotherapy (two-phase treatment)
- Where
- Canada
- Volunteers
- 40 people
- Sponsor
- University Health Network, Toronto
Neurocognitive Dysfunction, Brain Metastases
CBF and NCF Changes With Brain Radiation
This study will be a dual-arm prospective longitudinal cohort study for patients with brain metastases, at least one of which is appropriate for radiotherapy, to explore brain and cognitive changes following SRS or WBRT and…
- Trial name
- NCT03606421
- Testing
- SRS and neurocognitive assessments, WBRT and neurocognitive assessments
- Where
- Canada
- Volunteers
- 110 people
- Sponsor
- University Health Network, Toronto
Cardiovascular Diseases, Heart Diseases
WomenFocused Education in CArdiac REhabilitation (WECARE) Pilot RCT
The goal of this pilot clinical trial is to learn if a women-focused education program can improve knowledge, health, and well-being in women with heart disease who are attending cardiac rehabilitation.
- Conditions
- Cardiovascular Diseases, Heart Diseases, Health Knowledge, Attitudes, Practice, Behavior, Health
- Trial name
- WE-CARE (NCT07550036)
- Testing
- Cardiac College for Women, Usual Cardiac Rehab Education
- Where
- 3 sites in Canada
- Volunteers
- 50 people
- Sponsor
- University Health Network, Toronto
Osteoarthritis, Knee
Autologous BMA vs Saline and LAM + LP-PRP vs Saline Evaluations in Knee OA
ABLE OA is a Health Canada authorized (phase II/III) trial [Parent Control #: 263591]. A multi-center, prospective, double-blinded, randomized, placebo-controlled adaptive trial to evaluate the efficacy of two minimally…
- Trial name
- ABLE-OA (NCT05517434)
- Testing
- Bone Marrow Aspirate (BMA): Minimally manipulated autologous cellular preparation, Lipoaspirate Micronized + Leukocyte-Poor Platelet-Rich Plasma (LAM + LP-PRP): Minimally manipulated autologous cellular preparations
- Where
- 2 sites in Canada
- Volunteers
- 148 people
- Sponsor
- University Health Network, Toronto
Patient Satisfaction, Ovarian Cancer
Feasibility of CALM in Patients With Ovarian Cancer
The goal of this feasibility trial is to determine the feasibility and acceptability of implementing a brief evidence-based psychotherapeutic intervention, Managing Cancer And Living Meaningfully (CALM), at the time of a new…
- Trial name
- NCT06459271
- Testing
- Managing Cancer And Living Meaningfully (CALM)
- Where
- Canada
- Volunteers
- 50 people
- Sponsor
- University Health Network, Toronto
Breast Cancer, Lung Cancer
Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
This study will collect, annotate, and sequence biospecimens (blood, tissue, urine, saliva and surgery drainage) from patients across different cancer types to detect molecular residual disease (MRD).
- Conditions
- Breast Cancer, Lung Cancer, Melanoma, Gynecologic Cancer
- Trial name
- SHERLOCK (NCT07524114)
- Where
- Canada
- Volunteers
- 7,000 people
- Sponsor
- University Health Network, Toronto
ER-positive, HER2-negative Breast Cancer, Breast Cancer Stage I
Capecitabine in ER+/HER2-negative Breast Cancer
This is a Phase 2 study for patients with resected Stage I-III HR+/HER2-negative breast cancer with detected molecular residual disease (MRD+) following standard neo/adjuvant and locoregional therapy delivered with curative…
- Conditions
- ER-positive, HER2-negative Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III
- Trial name
- NCT07631052
- Testing
- Capecitabine
- Where
- Canada
- Volunteers
- 15 people
- Sponsor
- University Health Network, Toronto
Cancer
Positioning in RT - Supine vs. Upright
This is a single-center, non-therapeutic prospective pilot cohort study evaluating patient-reported comfort levels between upright and supine positioning in patients receiving radiation therapy across all age groups using a…
- Trial name
- Position in RT (NCT07765069)
- Testing
- Upright positioning chair
- Where
- Canada
- Volunteers
- 105 people
- Sponsor
- University Health Network, Toronto
Parkinson's Disease (PD), Essential Tremor
LIFUS For Neurological Disorders
Low intensity focused ultrasound (LIFUS) has the potential to be used as a means of non-invasive neuro-modulation. To this day, the use of LIFUS is under investigation.
- Conditions
- Parkinson's Disease (PD), Essential Tremor, Orthostatic Tremor, Dystonia
- Trial name
- NCT07417280
- Testing
- LIFUS
- Where
- Canada
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- University Health Network, Toronto
Brain Neoplasms, Liquid Biopsy
BRAINFUL (BRAIN Tumor Focused Ultrasound-enabled Liquid Biopsy) Trial
Background: Accessing brain tumor material for pathological diagnosis requires invasive procedures that carry risk to patients including brain hemorrhages and death.
- Trial name
- BRAINFUL (NCT04940507)
- Testing
- Magnetic Resonance Guided Focused Ultrasound Tumor Ablation and Liquid Biopsy Acquisition, Magnetic Resonance Guided Focused Ultrasound Thalamotomy
- Where
- Canada
- Volunteers
- 50 people
- Sponsor
- University Health Network, Toronto
Metastatic NSCLC - Non-Small Cell Lung Cancer, OligoProgressive Metastatic Disease
ctDNA-Guided CURB for OPD mNSCLC on TKI (CURB-TKI)
This is an open-label, prospective single arm Phase II trial that investigates the role of ablative stereotactic body radiation therapy (SBRT) in oncogene driven metastatic non-small cell lung cancer (mNSCLC) patients with…
- Trial name
- CURB-TKI (NCT06813664)
- Testing
- Radiotherapy
- Where
- Canada
- Volunteers
- 60 people
- Sponsor
- University Health Network, Toronto
Neuro-Degenerative Disease
3T MRI in Patients With Deep Brain Stimulation (DBS)
Deep brain stimulation (DBS) is an established treatment for advanced Parkinson's disease, medically refractory tremor, dystonia and obsessive compulsive disorder.
- Trial name
- NCT03153670
- Testing
- fMRI
- Where
- Canada
- Volunteers
- 250 people
- Sponsor
- University Health Network, Toronto
Bipolar Depression
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression
This study is an open-label, single-arm, proof-of-concept study, wherein treatment resistant bipolar depression (TRBD) participants will receive one 25 mg dose of oral psilocybin accompanied by preparatory, monitoring, and…
- Trial name
- Psilo-BD (NCT06506019)
- Testing
- Psilocybin, Functional MRI
- Where
- Canada
- Volunteers
- 30 people
- Sponsor
- University Health Network, Toronto